Dear Dr. Roach: My daughter, who is 50, recently went to a urologist for bladder retention issues. She had several tests performed. My daughter’s doctor told her that the diagnosis is “overactive ...

Proper urinary elimination is a key indicator of your overall health, especially as you get older. If your ability to urinate is impaired, it can cause a wide variety of other conditions. Impaired ...

Myrbetriq (mirabegron) is a brand-name drug that’s prescribed for overactive bladder in adults and certain children. It’s an extended-release medication. As with other drugs, Myrbetriq can cause side ...

The approval was based on data from the pivotal phase 3 EMPOWUR study. The Food and Drug Administration (FDA) has approved Gemtesa ® (vibegron; Urovant Sciences) for the treatment of overactive ...

Treatment with UGN-102 in patients with recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer demonstrated beneficial responses. Patients with recurrent low-grade intermediate-risk ...

Pyropheophorbide a–bisaminoquinoline conjugate lipid nanoparticles (PPBC LNPs), formulated with lipid-based excipients and assembled using microfluidics, exhibit excellent biocompatibility and ...